







| 7:30 - 8:10 | Registration and Breakfast | Speaker | |
| 8:10 - 8:20 | Welcome | Dr. Kutryk | |
| Session 1 Room: The Grand Hall Ballroom Session Objectives:
| |||
| 8:20 - 8: 40 | CAD Presentation with panel discussion | Dr. DiFabio | |
| 8:40 - 9:00 | Resistant Chronic Stable Angina Treatment case presentation CAD with panel discussion | Dr. Sakr | |
| 9:00 - 9:20 | Angina with Non-Obstructive Coronary Arteries (ANOCA): Essential Insights for Clinicians | Dr. Kutryk | |
| 9:20 - 9:40 | Non-Invasive Imaging in Cardiovascular Disease: When and Which Test to Select | Dr. Abazid | |
| 9:40-10:00 | Questions with Panel Discussion | ||
| 10:00 - 10:15 | Break | ||
| Session 2 Room: The Grand Hall Ballroom Session Objectives:
| |||
| 10:15 - 10:35 | Significant CAD on Invasive Angiography: How to Define, Measure, and Interpret | Dr. Woolridge | |
| 10:35 - 10:55 | Lipid Profile Beyond LDL Cholesterol: When to Assess and What Targets to Aim For | Dr. Azzola | |
| 11:15 - 11:35 | Cardiovascular Risk Assessment in Asymptomatic Patients: Clinical Risk Scores vs Calcium Scoring | Dr. Abazid | |
| 11:35 - 11:55 | Albumin-Creatinine Ratio (ACR) and Cardiovascular Risk: What We Need to Know | Dr. Berry | |
| 11:55- 12:15 | Questions with Panel Discussion | ||
| 12:15 - 13:00 | Lunch - Sponsored by Penumbra | Dr. Woolridge | |
| Session 3 Room: The Grand Hall Ballroom Session Objectives:
| |||
| 13:00 - 13:20 | Premature Ventricular Contractions (PVCs)/Non-sustained VT: When to Be Concerned and What Management Strategies to Consider | Dr. Garg | |
| 13:20 - 13:40 | The Minimally Invasive & Robotic Revolution in Cardiac Surgery | Dr. Bisleri | |
| 13:40 - 14:00 | Advances in TAVR Technology and the Importance of Early Referral (Recorded) | Dr. Fam | |
| 14:00 - 14:20 | EP round: Case presentation. | Dr. Garg | |
| 14:20 – 15:00 | Interesting Cases From SAH (Pacemaker): Woolridge, Abazid, Kutryk, Garg, Carissa & Katie | GROUP | |
| The session will present 8–10 interesting and challenging cases from SAH, including the clinical scenario, MCQs on investigations, and the final diagnosis | |||
| Cases may include cardiac tumors, coronary anomalies, amyloidosis, sarcoidosis, and other rare or challenging cardiac conditions | |||
| 15:00 - 15:45 | Questions with Panel Discussion | ||
| 15:45 – 16:00 | Closing Remarks | ||